CULTURING AND DIFFERENTIATING NEURAL PRECURSOR CELLS

• US 20100323444A1
• Filed: 06/28/2010
• Published: 12/23/2010
• Est. Priority Date: 11/07/2003
• Status: Abandoned Application

• Current Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Original Assignee: University of Florida Research Foundation, Incorporated (State University System of Florida)
• Inventors: Scheffler, Bjorn, Walton, Noah, Goetz, Antje K., Steindler, Dennis A.
• Application Number:
  US12/824,872
• Publication Number:
  US 20100323444A1
• Time in Patent Office: Days
• US Class Current: 435/377
• CPC Class Codes: A61P 25/16 Anti-Parkinson drugs
• CPC Class Codes: A61P 25/28 for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• CPC Class Codes: C12N 2500/84 from mammals
• CPC Class Codes: C12N 2501/11 Epidermal growth factor [EGF]
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 5/0623 Stem cells

Abstract

Systems and methods have been developed for large-scale propagation and differentiation of populations of neurons and glia from neural precursor cells derived from postnatal brain. Under culture conditions containing pituitary extract and mitogenic factors, cells derived from neural stem cells can be attached to a substrate, maintained and serially passaged in culture. Upon removal of mitogenic factors, clusters of neural progenitor cells can be induced that co-express markers of neural stem cells and immature neurons. Unlimited numbers of cells at characterized stages of neurogenesis can be produced. Upon maturation, neuronal cells extend processes and differentiate into mature neuronal phenotypes capable of generating action potentials.

Claims

1. A method for culturing neural precursor cells comprising the steps of:

(a) isolating tissue comprising neural precursor cells from an animal subject;

(b) dissociating the tissue to single cells; and

(c) attaching the single cells to a substrate in medium comprising pituitary extract and mitogenic factors EGF and bFGF, for a duration of time sufficient to produce a culture comprising at least one cell type that is proliferating and/or differentiated.

2. The method of claim 1, further comprising the step (d) of culturing the cells in medium lacking mitogenic factors.

3. The method of claim 1, wherein the medium comprises N2 components.

4. The method of claim 1, wherein the cell type is an immature precursor cell that expresses phenotypic markers of both neural stem cells and glial cells, but not markers of neuronal cell lineage.

5. The method of claim 4, wherein the immature precursor cell is passaged in culture.

6. The method of claim 2, wherein the cell type is a rapidly dividing intermediate cell that is produced in culture about 1 day after withdrawal of mitogenic factors, and expresses both phenotypic markers of neural stem cells and phenotypic markers of neuronal lineage, but not the glial cell marker GFAP.

7. The method of claim 6, wherein the cell expresses the neural stem cell marker nestin, the immature glial cell marker A2B5, and the early neuronal cell marker β

-III tubulin.

8. The method of claim 6, wherein the intermediate neural progenitor cell expresses nestin and markers of early neuronal lineage comprising β

-III tubulin and Dlx-2, but not markers of later neuronal lineage including MAP2, NeuN and GAD.

9. The method of claim 2, wherein the cell type is a SVZ progenitor cell that is produced in culture about 2-4 days after withdrawal of mitogenic factors, and expresses both phenotypic markers of neural stem cells and phenotypic markers of neuronal lineage, but not the glial cell marker GFAP.

10. The method of claim 9, wherein the SVZ progenitor cell expresses nestin and markers of early neuronal lineage comprising β

-III tubulin and Dlx-2, and at least one marker of late neuronal lineage selected from the group consisting of MAP2, NeuN, and GAD.

11. The method of claim 2, wherein the medium in step (d) further comprises retinoic acid, added to the culture medium following withdrawal of mitogenic factors, to induce differentiation of neurons.

12. The method of claim 11, wherein the cell type is a differentiated neuron capable of generating an action potential.

13. The method of claim 11, wherein the cell type is a bipolar cell.

14. The method of claim 11, wherein the cell type is a GABAergic neuron that expresses glutamic acid decarboxylase (GAD).

15. The method of claim 1, wherein the cell type is a glial cell.

16. The method of claim 15, wherein the glial cell is an astrocyte or an oligodendrocyte.

17. The method of claim 1, wherein the culture comprises about 40,000 to 80,000 cells/cm² of surface area.

18-27. -27. (canceled)